Open the mobile version, with barcode scanning
Class III Terminated

Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC.

Why: Failed Lozenge Specifications; Lozenges are overly thick, overly soft, and sub and superpotent.

Company
GlaxoSmithKline Consumer Healthcare; dba-GlaxoSmithKline
Aiken, SC, United States
Reported
Apr 30, 2014
Recall started
Feb 20, 2014
Ended
Jan 20, 2017
Where sold
U.S. Nationwide
Amount
189,900 20 ct Vials, 145,068 81 ct Vials
Full product description
Nicorette (nicotine polacrilex) Lozenges Mini, 4 mg, Original Flavor, 20 Lozenge and 81 Lozenge Vials, OTC. Distributed by GlaxoSmithKline Consumer Healthcare, LP, Moon Township, PA 15108, Made in Switzerland. 20 Count NDC: 0135-0509-04, 81 Count NDC: 0135-0509-02.
Lots / codes affected
(20 ct) Lot #14337 (exp 7/15), 14398 (exp 9/15) & 14510 (exp 9/15); (81 ct) Lot #14336 (exp 7/15), 14347 (exp 7/15), 14378 (9/15), 14563 (exp 9/15)

Class I: could cause serious harm or death. Class II: could cause temporary or treatable problems. Class III: unlikely to cause harm.